Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 14, 2020Australasian Journal of ParamedicineOpen Access

Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer’s Disease Transgenic Mouse Model at an Early Disease Stage

View Full Paper
Ask AI
Bookmark
Share

Authors

WFWarnakulasuriya Mary Ann Dipika Binosha FernandoIMIan MartinsMMMichael Morici

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fernando et al. (2020) studied this question.

synapsesocial.com/papers/69d737b4b54ccf0cfef3089ehttps://doi.org/10.3233/jad-190120
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The 5XFAD Mouse Model of Alzheimer’s Disease Exhibits an Age-Dependent Increase in Anti-Ceramide IgG and Exogenous Administration of Ceramide Further Increases Anti-Ceramide Titers and Amyloid Plaque Burden2015 · 74 citations
  2. 2Cued and Contextual Fear Conditioning in Mice2004 · 86 citations
  3. 3Emotion Circuits in the Brain2000 · 8,524 citations
  4. 4A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway2016 · 18 citations